Indeed, recurrent mutations in PBRM1, BAP1 and TP53 and loss of copy number of CDKN2A and RB1 have been described to cooperate with VHL inactivation in ccRCC as well [6]. The gene discussed is VHL; the disease is nonpapillary renal cell carcinoma.